Report cover image

Drug Eluting Stents (DES) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Jul 29, 2022
Length 142 Pages
SKU # GBDT17376132

Description

Drug Eluting Stents (DES) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Drug Eluting Stents (DES) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Drug Eluting Stents (DES) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.

Scope
  • Extensive coverage of the Drug Eluting Stents (DES) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Drug Eluting Stents (DES) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Drug Eluting Stents (DES) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

142 Pages
  • About GlobalData
    • Drug Eluting Stents (DES) Overview
    • Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
    • Drug Eluting Stents (DES) - Pipeline Products by Territory
    • Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
    • Drug Eluting Stents (DES) - Pipeline Products by Estimated Approval Date
    • Drug Eluting Stents (DES) - Ongoing Clinical Trials
    • Drug Eluting Stents (DES) Companies - Pipeline Products by Stage of Development
    • Drug Eluting Stents (DES) - Companies Pipeline Products by Stage of Development
    • Abbott Vascular Inc Company Overview
    • Adcomp Technologies Inc. Company Overview
    • Advanced Bifurcation Systems Inc Company Overview
    • Aeon Bioscience Company Overview
    • B. Braun Melsungen AG Company Overview
    • Biosensors International Group Ltd Company Overview
    • Biotronik AG Company Overview
    • Biotronik SE & Co KG Company Overview
    • Boston Scientific Corp Company Overview
    • Cardionovum GmbH Company Overview
    • Cardiorev Pte Ltd (Inactive) Company Overview
    • Columbia University Company Overview
    • Concept Medical Inc Company Overview
    • Cordis Corp Company Overview
    • DISA Vascular (Pty) Ltd Company Overview
    • Elixir Medical Corp Company Overview
    • Envision Scientific Pvt Ltd Company Overview
    • I.B.S. S.p.A. Company Overview
    • InspireMD Inc Company Overview
    • JW Medical Systems Ltd Company Overview
    • Kaneka Corp Company Overview
    • MangoGen Pharma Inc Company Overview
    • Medinol Ltd Company Overview
    • Medlogics Device Corp (Inactive) Company Overview
    • Medtronic Plc Company Overview
    • MicroPort Scientific Corp Company Overview
    • MIV Therapeutics Inc Company Overview
    • NuVascular Technologies Inc Company Overview
    • Relisys Medical Devices Ltd Company Overview
    • REVA Medical Inc Company Overview
    • Sahajanand Medical Technologies Pvt Ltd Company Overview
    • Shanghai BIOMAGIC Medical Device Co Ltd Company Overview
    • Shanghai MicroPort Medical Group Co Ltd Company Overview
    • Sino Medical Sciences Technology Inc Company Overview
    • Stentys SA Company Overview
    • Svelte Medical Systems Inc Company Overview
    • Terumo Corp Company Overview
    • Terumo Interventional Systems Company Overview
    • TissueGen Inc Company Overview
    • Translumina Therapeutics LLP Company Overview
    • University of Strathclyde Company Overview
    • VasoTech Inc. Company Overview
    • Jul 08, 2022: Cordis Names Bryan Loo President of Asia-pacific Region
    • Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
    • Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022
    • Feb 10, 2022: Contego Medical Announces Hiring of Steve MacKinnon, Chief Commercialization Officer
    • Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
    • Dec 09, 2021: Cordis appoints Dr. George Adams to Chief Medical Officer
    • Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
    • Dec 02, 2021: FDA: August 7, 2019 update: Treatment of peripheral arterial disease with paclitaxelcoated balloons and paclitaxel-eluting stents potentially associated with increased mortality
    • Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China
    • Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
    • Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021
    • Nov 02, 2021: Cordis Names Muscari President Of The Americas
    • Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
    • Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center
    • Sep 15, 2021: Opto Circuits Announces Unaudited Standalone Financial Results For The First Quarter Ended 30th June 2021
    • Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
    • Aug 17, 2021: Opto Circuits (India) Announces Financial Results for the Year Ended 31st March 2021
    • Aug 17, 2021: Opto Circuits (India) Announces Board Changes
    • Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
    • Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.